Conditions: Esophageal Cancer
Intervention Type: Biological
Intervention Name: LY6K, VEGFR1, VEGFR2
Clinical Trials
The following are clinical trials from the Healia Clinical Trials Information Database that are researching the effect of the "Biological" intervention "LY6K, VEGFR1, VEGFR2" on "Esophageal Cancer".
-
Phase 1 Study of Multiple Peptide Vaccine Therapy and GM-CSF in Treating Patients With Esophageal Cancer
NCTID: NCT00561275
